InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Browse the full record of transactions filed by Chang Carmen, Director. Officer active across 6 companies, notably Monte Rosa Therapeutics, Inc.. Aggregated, 13 disclosures have been published. Total volume traded: €5m. The latest transaction was filed on 24 May 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032322:0·
08,655 shares0
Common Stock
SEC:0001209191-22-029409:0·
€5m2,631,578 shares@ €1.74670.23% mcap100.0% of flow
Common Stock
SEC:0001209191-22-024315:0·
Ideal exit: 6 Jan 2023 (T+270)
€43,94637,570 shares@ €1.1697100.0% of flow
Common Stock
SEC:0001209191-21-071268·
€43,94637,570 shares@ €1.169750.0% of flow
Common Stock
SEC:0001209191-21-071268:0·
022,985 shares0
Common Stock
SEC:0001209191-21-062867·
022,985 shares0
Common Stock
SEC:0001209191-21-062867:0·
1,851,852 shares
Common Stock
SEC:0001209191-21-061093·
Ideal exit: 15 Jul 2022 (T+270)
1,851,852 shares
Common Stock
SEC:0001209191-21-061093:0·
Ideal exit: 15 Jul 2022 (T+270)
2,715,968 shares
Common Stock
SEC:0001209191-21-044039·
5,864,718 shares
Common Stock
SEC:0001209191-21-044190·
2,715,968 shares
Common Stock
SEC:0001209191-21-044039:0·
5,864,718 shares
Common Stock
SEC:0001209191-21-044190:0·
13 of 13 declarations
About Chang Carmen
Carmen Chang is a Board Member at Monte Rosa Therapeutics, Inc., Bright Health Group Inc., and Trevi Therapeutics, Inc. She brings valuable expertise in corporate governance and strategy. Her role involves overseeing operations and ensuring that decisions made align with the long-term goals of the companies.
